Sai Life Sciences has developed an integrated cell permeability platform to support drug discovery through automation and scalable high-throughput screening. […]
United Nations Global Compact (UNGC): A Progress Update
7 Sep 2022
Last year, in August 2021, Sai Life Sciences became a signatory of the United Nations Global Compact (UNGC), the world’s largest sustainability initiative. As a signatory, we committed ourselves to adop the Ten Principles of the UNGC on human rights, labour, environment and anti-corruption, reinforcing our commitment to corporate responsibility and sustainability.
In line with this commitment, we are pleased to report that we have submitted our annual Communication on Progress (COP). Our COP meets all minimum requirements and has qualified for the GC Active level. Our COP and the self-assessment are now publicly available on the Global Compact website.
We remain committed to this journey and are looking to improve policy implementation and increase transparency to progress toward achieving GC Advanced status.
Related News
Sai Life Sciences and AstraZeneca have published a study titled “ReactIR Monitoring of Turbo-Hauser Base Formation Enables a Robust Iodination […]
21 May 2026
As drug discovery programs increasingly demand faster optimization cycles and access to broader chemical space, advanced chemistry approaches are moving […]